Work

Nanoformulation of the PARP Inhibitor Olaparib Enables Radiosensitization of a Radiation-Resistant Prostate Cancer Model

Year: 2016

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2016.06.2120

Authors: P. Baldwin, A.L. Van De Ven, N. Seitzer, S. Clohessy, R.A. Cormack, M. Makrigiorgos, P.P. Pandolfi, S. Sridhar

Institutions: Northeastern University, Beth Israel Deaconess Medical Center, Harvard University, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2528345273

FWCI: 0.359

Cites:

Cited by: 3

Related to: 10